Abstract. To 
ceptors in spontaneous GH, Prl and cortisol secretion in man.
Extensive investigation in recent years has estab¬ lished the presence within the central nervous system of opiate receptors and of several peptides with opiate-like activity (Hughes et al. 1975 ; Pert & Snyder 1973) . Since then, progress has been made in the investigation of the role of opioid endogen¬ ous substances in the regulation of the endocrine system and many studies have provided evidence that morphine, endorphins and their receptors plays a role in regulating pituitary hormone secre¬ tion in experimental animals (Meites et al. 1979) .
The relation of opiate receptors to human neuroendocrine function is less clear. Studies reporting the effects of the opiate receptor blocker naloxone on basal and stimulated pituitary hormone release led to inconclusive results (Rubin et al. 1979; Morley et al. 1980; Grossman et al. 1981; Delitala et al. 1981; Spiler & Molitch 1980; Serri et al. 1981) . However, morphine and ß-endorphin have been shown to elevate prolactin (Prl) but not growth hormone (GH) or cortisol (Tolis et al. 1975 (Tolis et al. , 1978 Catlin et al. 1980 ). Further, a long acting analogue of met-enkephalin stimulated GH (and Prl) ability of morphine, ß-endorphins and met-enke-phalin to stimulate rat GH and Prl release in a dose-dependent fashion is well recognized (Meites et al. 1979) . Naloxone has been shown to suppress basal and stress stimulated Prl in rodents and non-human primates (Bruni et al. 1977; Gold et al. 1979 ). Moreover, a significant reduction of basal and stimulated GH secretion following naloxone has been described in rats and goats (Bruni et al. 1977; Hart & Cowie 1978) . These data and other experimental evidence would suggest that, in these species, endogenous-like peptides may participate in the regulation of Prl and GH secretion. The action of the opiates on the ACTH-adrenal axis is less clear. Acute administration of morphine has been shown to elevate corticosterone levels whereas chronic administration reduced ACTH and corti¬ costerone secretion in the rat (Meites et al. 1979 ).
However, the administration of high naloxone doses resulted in a dose-related elevation of plasma corticosterone in the mouse and in the opiate-naive rat (Eisenberg 1980 (Grossman et al. 1981) . On the other hand, naloxone was reported to diminish slightly the GH response to arginine (Morley et al. 1980 ) but not to L-dopa or apo-morphine (Lai et al. 1979 
